Vertex/CRISPR Partnered Cell Therapy Shows Encouraging Response In Sickle Cell Disease, Thalassemia Patients - CRISPR Therapeutics  ( NASDAQ:CRSP ) , Vertex Pharmaceuticals  ( NASDAQ:VRTX )